| 7135487 |
Sulphonamide derivatives |
Macklin Brian Arnold, Stephen R. Baker, Thomas John Bleisch, Buddy Eugene Cantrell, Ana Maria Escribano +6 more |
2006-11-14 |
$197,191,000 |
| 7034045 |
Monofluoroalkyl derivatives |
David Michael Bender, Buddy Eugene Cantrell, Andrew Hendley Fray, Winton D. Jones, William David Miller +3 more |
2006-04-25 |
$105,745,000 |
| 6713516 |
Sulphonamide derivatives |
Macklin Brian Arnold, David Michael Bender, Andrew Hendley Fray, Winton D. Jones, Paul Leslie Ornstein +2 more |
2004-03-30 |
$108,187,000 |
| 6693137 |
Sulphonamide derivatives |
Macklin Brian Arnold, David Michael Bender, Buddy Eugene Cantrell, Winton D. Jones, Paul Leslie Ornstein +4 more |
2004-02-17 |
$457,216,000 |
| 6515026 |
Sulphonamide derivatives |
Macklin Brian Arnold, Paul Leslie Ornstein, Hamideh Zarrinmayeh, Dennis M. Zimmerman |
2003-02-04 |
$165,242,000 |
| 6358982 |
Heterocyclyl sulphonamide derivatives |
Buddy Eugene Cantrell, Paul Leslie Ornstein, Hamideh Zarrinmayeh, Dennis M. Zimmerman |
2002-03-19 |
$63,225,000 |
| 6358981 |
Sulphonamide derivatives |
Macklin Brian Arnold, David Michael Bender, Andrew Hendley Fray, Winton D. Jones, Paul Leslie Ornstein +2 more |
2002-03-19 |
$63,225,000 |
| 6303816 |
Sulphonamide derivatives |
Macklin Brian Arnold, Stephen R. Baker, David Bleakman, Thomas John Bleisch, Buddy Eugene Cantrell +8 more |
2001-10-16 |
$145,417,000 |
| 6251928 |
Treatment of alzheimer's disease employing inhibitors of cathepsin D |
Jill A. Panetta, Michael LeRoy Phillips, Jon K. Reel, John Kevin Shadle, Sandra K. Sigmund +1 more |
2001-06-26 |
$203,013,000 |
| 6117883 |
Heterocyclic compounds |
Leander Merritt, Jon K. Reel, Celia A. Whitesitt |
2000-09-12 |
$216,560,000 |
| 5814646 |
Inhibitors of amyloid beta-protein production |
Lawrence Joseph Heinz, Jill A. Panetta, Michael LeRoy Phillips, Jon K. Reel, John Kevin Shadle +1 more |
1998-09-29 |
$221,221,000 |
| 5747517 |
Benzylidene rhodanines |
Jill A. Panetta, Michael LeRoy Phillips, Jon K. Reel, John Kevin Shadle, Sandra K. Sigmund +1 more |
1998-05-05 |
$134,602,000 |
| 5693633 |
Angiotensin II antagonists |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1997-12-02 |
$77,823,000 |
| 5624937 |
Chemical compounds as inhibitors of amyloid beta protein production |
Jon K. Reel, Celia A. Whitesitt |
1997-04-29 |
$40,467,000 |
| 5612360 |
Angiotensin II antagonists |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1997-03-18 |
$65,116,000 |
| 5571925 |
Angiotensin II antagonists |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Mitchell I. Steinberg +1 more |
1996-11-05 |
$72,135,000 |
| 5569768 |
Angiotensin II antagonists |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1996-10-29 |
$52,853,000 |
| 5563278 |
Angiotensin II antagonists |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Mitchell I. Steinberg +1 more |
1996-10-08 |
$20,245,000 |
| 5556981 |
Angiotensin II antagonist intermediates |
Donald B. Boyd, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz, William Pfeifer +5 more |
1996-09-17 |
$60,282,000 |
| 5484780 |
Angiotensin II antagonists |
Donald B. Boyd, Kenneth Lee Hauser, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz +6 more |
1996-01-16 |
$19,679,000 |
| 5401851 |
Angiotensin II antagonists |
Donald B. Boyd, Kenneth Lee Hauser, Sherryl L. Lifer, Winston S. Marshall, Alan David Palkowitz +6 more |
1995-03-28 |
$40,430,000 |
| 5312936 |
Angiotensin II antagonists |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Mitchell I. Steinberg +1 more |
1994-05-17 |
$48,226,000 |
| 5073566 |
Angiotensin II antagonist 1,3-imidazoles and use thereas |
Sherryl L. Lifer, Winston S. Marshall, Fariborz Mohamadi, Jon K. Reel, Mitchell I. Steinberg +1 more |
1991-12-17 |
$106,888,000 |
| 4658061 |
9-aminoalkylfluorenes |
William B. Lacefield |
1987-04-14 |
$62,375,000 |
| 4452745 |
9-Aminoalkylfluorenes |
William B. Lacefield |
1984-06-05 |
$3,783,000 |
